This October, Malin Hultqvist Davidsson will be attending Cell & Gene Meeting on the Mesa in Phoenix, Arizona – one of the leading partnering events focused on cell and gene therapies.
The meeting brings together biotech and pharma companies, investors, technology providers, and service partners from across the industry, making it an excellent opportunity to discuss the latest scientific advances, development strategies, and the challenges involved in bringing innovative therapies to patients.
At Redoxis, we are seeing continued growth in projects involving advanced therapeutics, including cell and gene therapies. Our expertise in preclinical efficacy studies, immunology, inflammation, and autoimmune disease models allows us to support developers with robust, decision-enabling data throughout the preclinical phase.
If you are attending the meeting and would like to discuss how Redoxis can support your preclinical program, I would be delighted to connect.